These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3840886)
1. Evidence for common precursors but differential processing of VIP and PHM in VIP-producing tumors. Fahrenkrug J Peptides; 1985; 6(3):357-61. PubMed ID: 3840886 [TBL] [Abstract][Full Text] [Related]
2. Cosecretion of peptide histidine methionine (PHM) and vasoactive intestinal peptide (VIP) in patients with VIP-producing tumors. Fahrenkrug J; Pedersen JH Peptides; 1986; 7(5):717-21. PubMed ID: 3797338 [TBL] [Abstract][Full Text] [Related]
3. Production of VIP- and PHM (human PHI)-related peptides in human neuroblastoma cells. Hoshino M; Yanaihara C; Ogino K; Iguchi K; Sato H; Suzuki T; Yanaihara N Peptides; 1984; 5(2):155-60. PubMed ID: 6548020 [TBL] [Abstract][Full Text] [Related]
4. Characterization and regional distribution of peptides derived from the vasoactive intestinal peptide precursor in the normal human brain. Fahrenkrug J; Emson PC J Neurochem; 1989 Oct; 53(4):1142-8. PubMed ID: 2769258 [TBL] [Abstract][Full Text] [Related]
5. Gene expression and transcript size of the prepro-peptide VIP/PHM-27 in normal human tissue. Schulte-Bockholt A; Meier DA; Hopp K; Stadelmann A; Otterson MF; Telford GL; Koch TR Neurosci Lett; 1993 Dec; 164(1-2):101-4. PubMed ID: 8152582 [TBL] [Abstract][Full Text] [Related]
6. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome. Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426 [TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP regulation of pro-vasoactive intestinal polypeptide/PHM-27 synthesis in human neuroblastoma cells. Hayakawa Y; Obata K; Itoh N; Yanaihara N; Okamoto H J Biol Chem; 1984 Jul; 259(14):9207-11. PubMed ID: 6086627 [TBL] [Abstract][Full Text] [Related]
8. Location of PHM/VIP mRNA in human gastrointestinal tract detected by in situ hybridization. Bredkjaer HE; Wulff BS; Emson PC; Fahrenkrug J Cell Tissue Res; 1994 May; 276(2):229-38. PubMed ID: 8020060 [TBL] [Abstract][Full Text] [Related]
9. Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter. Yamagami T; Ohsawa K; Nishizawa M; Inoue C; Gotoh E; Yanaihara N; Yamamoto H; Okamoto H Ann N Y Acad Sci; 1988; 527():87-102. PubMed ID: 2839091 [TBL] [Abstract][Full Text] [Related]
10. Peptide histidine methionine and vasoactive intestinal peptide: occurrence and relaxant effect in the human female reproductive tract. Palle C; Ottesen B; Jørgensen J; Fahrenkrug J Biol Reprod; 1989 Dec; 41(6):1103-11. PubMed ID: 2624870 [TBL] [Abstract][Full Text] [Related]
11. PreproVIP-derived peptides in tissue and plasma from patients with VIP-producing tumours. Rønnov-Jensen D; Gether U; Fahrenkrug J Eur J Clin Invest; 1991 Apr; 21(2):154-60. PubMed ID: 1647952 [TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide (VIP) and peptide histidine methionine (PHM) in human eccrine sweat glands: demonstration of innervation, specific binding sites and presence in secretions. Eedy DJ; Shaw C; Armstrong EP; Johnston CF; Buchanan KD Br J Dermatol; 1990 Jul; 123(1):65-76. PubMed ID: 2390496 [TBL] [Abstract][Full Text] [Related]
13. Co-existence and co-secretion of the structurally related peptides VIP and PHI. Fahrenkrug J Scand J Clin Lab Invest Suppl; 1987; 186():43-50. PubMed ID: 3474771 [TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel prepro VIP derived peptide. Yiangou Y; Requejo F; Polak JM; Bloom SR Biochem Biophys Res Commun; 1986 Sep; 139(3):1142-9. PubMed ID: 3767995 [TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal polypeptide (VIP) and peptide histidine methionine (PHM) in human penile corpus cavernosum tissue and circumflex veins: localization and in vitro effects. Kirkeby HJ; Fahrenkrug J; Holmquist F; Ottesen B Eur J Clin Invest; 1992 Jan; 22(1):24-30. PubMed ID: 1348474 [TBL] [Abstract][Full Text] [Related]
16. Distribution, plasma concentration, and in vivo prolactin-releasing activity of peptide histidine methionine in humans. Sasaki A; Sato S; Go MG; Shimizu Y; Murakami O; Hanew K; Yumita S; Andoh N; Sasano N; Yoshinaga K J Clin Endocrinol Metab; 1987 Oct; 65(4):683-8. PubMed ID: 3654914 [TBL] [Abstract][Full Text] [Related]
17. Structure and expression of the gene encoding the vasoactive intestinal peptide precursor. Linder S; Barkhem T; Norberg A; Persson H; Schalling M; Hökfelt T; Magnusson G Proc Natl Acad Sci U S A; 1987 Jan; 84(2):605-9. PubMed ID: 3025882 [TBL] [Abstract][Full Text] [Related]
18. Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse. Mikkelsen JD; Fahrenkrug J Brain Res; 1994 Sep; 656(1):95-107. PubMed ID: 7804850 [TBL] [Abstract][Full Text] [Related]
19. VIP and PHI in the pig pancreas: coexistence, corelease, and cooperative effects. Holst JJ; Fahrenkrug J; Knuhtsen S; Jensen SL; Nielsen OV; Lundberg JM; Hökfelt T Am J Physiol; 1987 Feb; 252(2 Pt 1):G182-9. PubMed ID: 3548423 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, cloning and expression in Escherichia coli of artificial genes coding for biologically active elongated precursors of the vasoactive intestinal polypeptide. Simoncsits A; Tjörnhammar ML; Kalman M; Cserpan I; Gafvelin G; Bartfai T Eur J Biochem; 1988 Dec; 178(2):343-50. PubMed ID: 3145201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]